Activation in vivo of the collagenase of Clostridium histolyticum by erythromycin lactobionate
Warter, A.; Schirardin, H.; Warter, J.
Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 183(2): 153-156
1989
ISSN/ISBN: 0037-9026 PMID: 2555034 Document Number: 344616
The authors demonstrate a previously not described increase, in vivo, in a mean proportion of 70%, of the enzymatic activity of the clostridium collagenase in rats by erythromycin lactobionate. The pathogenesis of this phenomenon cannot yet be explained.
Document emailed within 1 workday
Related Documents
Lin, H.-C.; Zhang, H.-T.; Jiang, H. 2017: Collagenase clostridium histolyticum for Peyronie's disease: a new minimally invasive and effective treatment Zhonghua Nan Ke Xue 23(9): 771-775Verstreken, F.; Degreef, I.; Decramer, A.; Libberecht, K.; Vanhove, W.; Datco, A.; Vanhaecke, J.; Clermont, D.; Duerinckx, J. 2016: Effectiveness and safety of collagenase Clostridium histolyticum in Dupuytren's disease : an observational study in Belgium Acta Orthopaedica Belgica 82(2): 397-404
Petrova, I.S.; Lagutina, L.S. 1973: The effect of Actinomyces fradiae 119 proteinases, trypsin and Clostridium histolyticum collagenase on insoluble collagen from the Achilles tendon Prikladnaia Biokhimiia i Mikrobiologiia 9(4): 506-511
Kane, M.P.; Bailie, G.R.; Moon, D.G.; Siu, I.; Eisele, G. 1994: Stability of erythromycin lactobionate in peritoneal dialysate solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 14(1): 79-81
Vinardell, P.; Planas, J.; Torralba, A. 1980: Inhibition of erythromycin lactobionate-induced writhing by analgesic drugs Il Farmaco; Edizione Pratica 35(3): 133-140
Mookhtiar, K.A.; Van Wart, H.E. 1992: Clostridium histolyticum collagenases: a new look at some old enzymes Matrix . Suppl 1: 116-126
Takahashi, S.; Seifter, S. 1972: New culture conditions for Clostirdium histolyticum leading to production of collagenase of high specific activity Journal of Applied Bacteriology 35(4): 647-657
Solov'eva, N.I.; Balaevskaia, T.O.; Makeeva, O.S.; Orekhovich, V.N. 1980: Isolation and properties of 3 Clostridium histolyticum collagenases Voprosy Meditsinskoi Khimii 26(5): 674-677
Mineo, T.C.; Cristino, B.; Ambrogi, V.; Reggio, S. 1989: Short-term prophylaxis with erythromycin lactobionate in patients undergoing lung surgery Minerva Chirurgica 44(22): 2337-2340
Lester, G.D.; Merritt, A.M.; Neuwirth, L.; Vetro-Widenhouse, T.; Steible, C.; Rice, B. 1998: Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies American Journal of Veterinary Research 59(3): 328-334
Tjaberg, T.B. 1974: Proteases of Clostridium botulinum. VI. the role of trypsin, Clostridium botulinum proteases and protease inhibitors in the formation and activation of toxin in growing cultures of Clostridium botulinum Acta Veterinaria Scandinavica 15(4): 487-506
Schmidt, K.G.; Rasmussen, J.W. 1984: Acute platelet activation induced by smoking. in vivo and ex vivo studies in humans Thrombosis and Haemostasis 51(2): 279-282
Müller, H.E. 1970: The in vitro identification and the in vivo action of Clostridium septicum neuraminidase Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie Virusforschung und Parasitologie. Originale 215(4): 530-535
Mitchell, W.M. 1970: The contamination of purified collagenase preparations by clostridiopeptidase B (clostripain): the potential effect of studies utilizing collagenase as a highly specific structural tool Johns Hopkins Medical Journal 127(4): 192-198
Majer, J.; Stanaszek, R.S.; Mueller, S.L.; Marti, G. 1978: N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(6): 673-676
Suzuki, J.B.; Booth, R.; Grecz, N. 1971: In vivo and in vitro release of Ca 45 from spores of clostridium botulinum type a as further evidence for spore germination Research Communications in Chemical Pathology and Pharmacology 2(1): 16-23
Klita, S.; Szafranśki, P. 1980: Comparison of the mechanism of action of cyclic 11,12-erythromycin a carbonate and erythromycin a Acta Biochimica Polonica 27(3-4): 213-220
Nicod, L.P.; Isler, P.; Chicheportiche, R.; Songeon, F.; Dayer, J.M. 1996: Production of prostaglandin E2 and collagenase is inhibited by the recombinant soluble tumour necrosis factor receptor p55-human gamma 3 fusion protein at concentrations a hundred-fold lower than those decreasing T cell activation European Cytokine Network 7(4): 757-763
Tschesche, H.; Fedrowitz, J.; Kohnert, U.; Michaelis, J.; Macartney, H.W. 1986: Matrix degrading proteinases from human granulocytes: type I, II, IIi collagenase, gelatinase and type IV, V-collagenase. a survey of recent findings and inhibition by gamma-anticollagenase Folia Histochemica et Cytobiologica 24(2): 125-131
Tsai, C.C.; Riemann, H.P. 1974: Relation of enterotoxigenic Clostridium perfringens type a to food poisoning. I. Effect of heat activation on the germination, sporulation and enterotoxigenesis of c. perfringens Journal of the Formosan Medical Association 73(11): 653-659